Cohort for Monitoring Patients With Venous Thromboembolic Disease

Launched by UNIVERSITY HOSPITAL, ROUEN · Jun 4, 2025

Keywords

ClinConnect Summary

This clinical trial is studying patients who have experienced a condition called venous thromboembolic disease, which includes deep vein thrombosis (a blood clot in a deep vein) and pulmonary embolism (a blood clot in the lungs). The goal is to better understand the risk of these conditions coming back after treatment and to find the right balance for long-term anticoagulant (blood-thinning) therapy. While this treatment can help prevent new clots, it can also lead to complications, so regular evaluation of risks and benefits is important.

To participate in this trial, you must be over 18 years old and have had at least one confirmed episode of venous thromboembolic disease. You should also have been hospitalized in the Internal Medicine Department and seen by an Internal Medicine physician. If you join the trial, you will be evaluated and monitored regularly to help improve understanding and management of this condition. This study is currently recruiting participants, and it aims to ensure that treatment is safe and effective for everyone involved.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• 1. Any patient over 18 years of age who has experienced at least one venous thromboembolic episode:
• • Deep vein thrombosis confirmed by Doppler ultrasound or CT venography,
• • Pulmonary embolism confirmed by CT angiography, ventilation/perfusion scan, or confirmed DVT episode with respiratory signs consistent with PE.
• • 2. Hospitalization in the Internal Medicine Department
• • 3. Consultation by an Internal Medicine physician
• • 4. File presented at the thrombosis multidisciplinary meeting
• Exclusion Criteria:
• • Thrombosis not meeting the inclusion criteria (cerebral venous thrombosis, mesenteric)